Skip to main content
. 2014 Nov 6;156(1):71–79. doi: 10.1210/en.2014-1627

Table 2.

Pituitary Tumorigenesis in Female ErbB Transgenic Mice, Age 11–13 Months

WT EGFR HER2
Total (n) 12 20 17 (9 T-neu and 8 N-neu)
% tumor penetrance or enlarged pituitary 8% 30% 41% (4 T-neu and 3 N-neu)
Circulating PRL levels (ng/mL) 22 ± 6 110 ± 20a 84 ± 18a
a

P < .05 vs WT.